Paper30833772
Drug developers switch gears to inhibit STING.
Sheridan C. Nat Biotechnol, 2019. Cited by 55 papers, by iCite.
Cite this record
ConductScience Library. Drug developers switch gears to inhibit STING. Papers, record 30833772. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30833772
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunity, Innate | Major topic |
| Inflammation | Major topic |
| Membrane Proteins | Major topic |
| Drug Development | |
| Humans | |
| STING Protein |
Source PubMed
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42416061 | cGAS-STING pathway in innate immunity and its cell-specific role in kidney diseases. | Front Immunol | 2026 | https://conductscience.org/library/papers/42416061 | PubMed |
| 40828197 | Interplay of cGAS-STING and ferroptosis: crosstalk, molecular mechanisms, and therapeutic prospects. | Arch Toxicol | 2025 | https://conductscience.org/library/papers/40828197 | PubMed |
| 40657041 | cGAS-STING Targeting Offers Novel Therapeutic Opportunities in Liver Diseases. | Drug Des Devel Ther | 2025 | https://conductscience.org/library/papers/40657041 | PubMed |
| 40552295 | The activation of cGAS-STING pathway offers novel therapeutic opportunities in cancers. | Front Immunol | 2025 | https://conductscience.org/library/papers/40552295 | PubMed |
| 40135812 | Targeted STING Activation Using Modified Ultrasound-Responsive Microbubbles Enhances Immune Checkpoint Blockade Against Melanoma. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40135812 | PubMed |
| 39920718 | cGAS-STING targeting offers therapy choice in lung diseases. | Biol Direct | 2025 | https://conductscience.org/library/papers/39920718 | PubMed |
| 38811577 | Small molecule induced STING degradation facilitated by the HECT ligase HERC4. | Nat Commun | 2024 | https://conductscience.org/library/papers/38811577 | PubMed |
| 38314681 | Role of TBK1 Inhibition in Targeted Therapy of Cancer. | Mini Rev Med Chem | 2024 | https://conductscience.org/library/papers/38314681 | PubMed |
| 37175853 | Role of cGAS-Sting Signaling in Alzheimer's Disease. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37175853 | PubMed |
| 36968217 | TAK1 deficiency promotes liver injury and tumorigenesis via ferroptosis and macrophage cGAS-STING signalling. | JHEP Rep | 2023 | https://conductscience.org/library/papers/36968217 | PubMed |
| 36926349 | cGAS-STING pathway as a potential trigger of immunosenescence and inflammaging. | Front Immunol | 2023 | https://conductscience.org/library/papers/36926349 | PubMed |
| 36632700 | The role of STING signaling in central nervous system infection and neuroinflammatory disease. | WIREs Mech Dis | 2023 | https://conductscience.org/library/papers/36632700 | PubMed |
| 36457340 | Molecular Function of cGAS-STING in SARS-CoV-2: A Novel Approach to COVID-19 Treatment. | Biomed Res Int | 2022 | https://conductscience.org/library/papers/36457340 | PubMed |
| 36051878 | Host-pathogen protein-nucleic acid interactions: A comprehensive review. | Comput Struct Biotechnol J | 2022 | https://conductscience.org/library/papers/36051878 | PubMed |
| 35303907 | The role of inflammation in neurodegeneration: novel insights into the role of the immune system in C9orf72 HRE-mediated ALS/FTD. | Mol Neurodegener | 2022 | https://conductscience.org/library/papers/35303907 | PubMed |
| 35281062 | Discordance in STING-Induced Activation and Cell Death Between Mouse and Human Dendritic Cell Populations. | Front Immunol | 2022 | https://conductscience.org/library/papers/35281062 | PubMed |
| 35116571 | Combinations of immunotherapy and radiation therapy in head and neck squamous cell carcinoma: a narrative review. | Transl Cancer Res | 2021 | https://conductscience.org/library/papers/35116571 | PubMed |
| 35084490 | Intervention of cGAS‒STING signaling in sterile inflammatory diseases. | J Mol Cell Biol | 2022 | https://conductscience.org/library/papers/35084490 | PubMed |
| 35008251 | Physical Forces and Transient Nuclear Envelope Rupture during Metastasis: The Key for Success? | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/35008251 | PubMed |
| 34884568 | Regulation of the Cell-Intrinsic DNA Damage Response by the Innate Immune Machinery. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34884568 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| STING1 | 340061 | PubTator's text mining | https://conductscience.org/library/genes/340061 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30833772
GET https://conductscience.org/api/papers/v1/30833772/cited_by?page=2